Month: April 2019

Lexington Biosciences to Consolidate its Common Shares

VANCOUVER, BRITISH COLUMBIA – April 25, 2018 – Lexington Biosciences, Inc. (CSE: LNB) (OTCQB: LXGTF) (the “Company” or “Lexington”) announces that effective at the opening of markets on April 26, 2019, the Company has consolidated its outstanding common shares (the “Shares”) on the basis of one (1) post‐consolidated Share for every ten (10) pre‐consolidated Shares

Read More

Lexington Biosciences Provides Update on Financial Situation

VANCOUVER, BRITISH COLUMBIA – April 2, 2018 – Lexington Biosciences, Inc. (CSE: LNB) (OTCQB: LXGTF) (the “Company” or “Lexington”) announced on February 14, 2019 that it had been unable to secure the necessary financing to advance the development of its HeartSentry technology.  The Company is currently considering its options, which may include selling the HeartSentry

Read More



Newsletter Updates

If you haven’t already done so, signup here to receive future editions and the latest company news direct to your inbox.

Latest News